Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biosimilar market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Genor BioPharma
BioXpress Therapeutics
BIOCAD
Intas Pharmaceuticals Limited
Reliance Life Sciences
Boehringer Ingelheim
Pfizer
Novartis
Biocon
Celltrion
Coherus BioSciences
Allergan plc
By Type:
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
By End-User:
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Market
-
1.3 Market Segment by Type
-
1.3.1 China Biosimilar Market Size and Growth Rate of Human Growth Hormones from 2016 to 2027
-
1.3.2 China Biosimilar Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.3 China Biosimilar Market Size and Growth Rate of Insulin from 2016 to 2027
-
1.3.4 China Biosimilar Market Size and Growth Rate of Peptides from 2016 to 2027
-
1.3.5 China Biosimilar Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
1.3.6 China Biosimilar Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biosimilar Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 China Biosimilar Market Size and Growth Rate of Chronic and Autoimmune Diseases from 2016 to 2027
-
1.4.3 China Biosimilar Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027
-
1.4.4 China Biosimilar Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
1.4.5 China Biosimilar Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilar Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilar by Major Types
-
3.4.1 Market Size and Growth Rate of Human Growth Hormones
-
3.4.2 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.3 Market Size and Growth Rate of Insulin
-
3.4.4 Market Size and Growth Rate of Peptides
-
3.4.5 Market Size and Growth Rate of Erythropoietin
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Biosimilar Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilar by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilar in Oncology
-
4.4.2 Market Size and Growth Rate of Biosimilar in Chronic and Autoimmune Diseases
-
4.4.3 Market Size and Growth Rate of Biosimilar in Growth Hormone Deficiency
-
4.4.4 Market Size and Growth Rate of Biosimilar in Infectious Diseases
-
4.4.5 Market Size and Growth Rate of Biosimilar in Others
5 Market Analysis by Regions
-
5.1 China Biosimilar Production Analysis by Regions
-
5.2 China Biosimilar Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biosimilar Landscape Analysis
-
6.1 North China Biosimilar Landscape Analysis by Major Types
-
6.2 North China Biosimilar Landscape Analysis by Major End-Users
7 Central China Biosimilar Landscape Analysis
-
7.1 Central China Biosimilar Landscape Analysis by Major Types
-
7.2 Central China Biosimilar Landscape Analysis by Major End-Users
8 South China Biosimilar Landscape Analysis
-
8.1 South China Biosimilar Landscape Analysis by Major Types
-
8.2 South China Biosimilar Landscape Analysis by Major End-Users
9 East China Biosimilar Landscape Analysis
-
9.1 East China Biosimilar Landscape Analysis by Major Types
-
9.2 East China Biosimilar Landscape Analysis by Major End-Users
10 Northeast China Biosimilar Landscape Analysis
-
10.1 Northeast China Biosimilar Landscape Analysis by Major Types
-
10.2 Northeast China Biosimilar Landscape Analysis by Major End-Users
11 Southwest China Biosimilar Landscape Analysis
-
11.1 Southwest China Biosimilar Landscape Analysis by Major Types
-
11.2 Southwest China Biosimilar Landscape Analysis by Major End-Users
12 Northwest China Biosimilar Landscape Analysis
-
12.1 Northwest China Biosimilar Landscape Analysis by Major Types
-
12.2 Northwest China Biosimilar Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Genor BioPharma
-
13.1.1 Genor BioPharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 BioXpress Therapeutics
-
13.2.1 BioXpress Therapeutics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 BIOCAD
-
13.3.1 BIOCAD Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Intas Pharmaceuticals Limited
-
13.4.1 Intas Pharmaceuticals Limited Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Reliance Life Sciences
-
13.5.1 Reliance Life Sciences Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Boehringer Ingelheim
-
13.6.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pfizer
-
13.7.1 Pfizer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Biocon
-
13.9.1 Biocon Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Celltrion
-
13.10.1 Celltrion Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Coherus BioSciences
-
13.11.1 Coherus BioSciences Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Allergan plc
-
13.12.1 Allergan plc Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biosimilar Market Size and Growth Rate of Human Growth Hormones from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Insulin from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Peptides from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biosimilar Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Chronic and Autoimmune Diseases from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
Figure China Biosimilar Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilar Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilar
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilar by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilar by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Human Growth Hormones
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Insulin
-
Figure Market Size and Growth Rate of Peptides
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilar by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilar by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Chronic and Autoimmune Diseases
-
Figure Market Size and Growth Rate of Growth Hormone Deficiency
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Others
-
Table China Biosimilar Production by Regions
-
Table China Biosimilar Production Share by Regions
-
Figure China Biosimilar Production Share by Regions in 2016
-
Figure China Biosimilar Production Share by Regions in 2021
-
Figure China Biosimilar Production Share by Regions in 2027
-
Table China Biosimilar Consumption by Regions
-
Table China Biosimilar Consumption Share by Regions
-
Figure China Biosimilar Consumption Share by Regions in 2016
-
Figure China Biosimilar Consumption Share by Regions in 2021
-
Figure China Biosimilar Consumption Share by Regions in 2027
-
Table North China Biosimilar Consumption by Types from 2016 to 2027
-
Table North China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure North China Biosimilar Consumption Share by Types in 2016
-
Figure North China Biosimilar Consumption Share by Types in 2021
-
Figure North China Biosimilar Consumption Share by Types in 2027
-
Table North China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table North China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biosimilar Consumption Share by End-Users in 2016
-
Figure North China Biosimilar Consumption Share by End-Users in 2021
-
Figure North China Biosimilar Consumption Share by End-Users in 2027
-
Table Central China Biosimilar Consumption by Types from 2016 to 2027
-
Table Central China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Central China Biosimilar Consumption Share by Types in 2016
-
Figure Central China Biosimilar Consumption Share by Types in 2021
-
Figure Central China Biosimilar Consumption Share by Types in 2027
-
Table Central China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Central China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biosimilar Consumption Share by End-Users in 2016
-
Figure Central China Biosimilar Consumption Share by End-Users in 2021
-
Figure Central China Biosimilar Consumption Share by End-Users in 2027
-
Table South China Biosimilar Consumption by Types from 2016 to 2027
-
Table South China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure South China Biosimilar Consumption Share by Types in 2016
-
Figure South China Biosimilar Consumption Share by Types in 2021
-
Figure South China Biosimilar Consumption Share by Types in 2027
-
Table South China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table South China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biosimilar Consumption Share by End-Users in 2016
-
Figure South China Biosimilar Consumption Share by End-Users in 2021
-
Figure South China Biosimilar Consumption Share by End-Users in 2027
-
Table East China Biosimilar Consumption by Types from 2016 to 2027
-
Table East China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure East China Biosimilar Consumption Share by Types in 2016
-
Figure East China Biosimilar Consumption Share by Types in 2021
-
Figure East China Biosimilar Consumption Share by Types in 2027
-
Table East China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table East China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biosimilar Consumption Share by End-Users in 2016
-
Figure East China Biosimilar Consumption Share by End-Users in 2021
-
Figure East China Biosimilar Consumption Share by End-Users in 2027
-
Table Northeast China Biosimilar Consumption by Types from 2016 to 2027
-
Table Northeast China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biosimilar Consumption Share by Types in 2016
-
Figure Northeast China Biosimilar Consumption Share by Types in 2021
-
Figure Northeast China Biosimilar Consumption Share by Types in 2027
-
Table Northeast China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biosimilar Consumption Share by End-Users in 2016
-
Figure Northeast China Biosimilar Consumption Share by End-Users in 2021
-
Figure Northeast China Biosimilar Consumption Share by End-Users in 2027
-
Table Southwest China Biosimilar Consumption by Types from 2016 to 2027
-
Table Southwest China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biosimilar Consumption Share by Types in 2016
-
Figure Southwest China Biosimilar Consumption Share by Types in 2021
-
Figure Southwest China Biosimilar Consumption Share by Types in 2027
-
Table Southwest China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biosimilar Consumption Share by End-Users in 2016
-
Figure Southwest China Biosimilar Consumption Share by End-Users in 2021
-
Figure Southwest China Biosimilar Consumption Share by End-Users in 2027
-
Table Northwest China Biosimilar Consumption by Types from 2016 to 2027
-
Table Northwest China Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biosimilar Consumption Share by Types in 2016
-
Figure Northwest China Biosimilar Consumption Share by Types in 2021
-
Figure Northwest China Biosimilar Consumption Share by Types in 2027
-
Table Northwest China Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biosimilar Consumption Share by End-Users in 2016
-
Figure Northwest China Biosimilar Consumption Share by End-Users in 2021
-
Figure Northwest China Biosimilar Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Genor BioPharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genor BioPharma
-
Figure Sales and Growth Rate Analysis of Genor BioPharma
-
Figure Revenue and Market Share Analysis of Genor BioPharma
-
Table Product and Service Introduction of Genor BioPharma
-
Table Company Profile and Development Status of BioXpress Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioXpress Therapeutics
-
Figure Sales and Growth Rate Analysis of BioXpress Therapeutics
-
Figure Revenue and Market Share Analysis of BioXpress Therapeutics
-
Table Product and Service Introduction of BioXpress Therapeutics
-
Table Company Profile and Development Status of BIOCAD
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD
-
Figure Sales and Growth Rate Analysis of BIOCAD
-
Figure Revenue and Market Share Analysis of BIOCAD
-
Table Product and Service Introduction of BIOCAD
-
Table Company Profile and Development Status of Intas Pharmaceuticals Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas Pharmaceuticals Limited
-
Figure Sales and Growth Rate Analysis of Intas Pharmaceuticals Limited
-
Figure Revenue and Market Share Analysis of Intas Pharmaceuticals Limited
-
Table Product and Service Introduction of Intas Pharmaceuticals Limited
-
Table Company Profile and Development Status of Reliance Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reliance Life Sciences
-
Figure Sales and Growth Rate Analysis of Reliance Life Sciences
-
Figure Revenue and Market Share Analysis of Reliance Life Sciences
-
Table Product and Service Introduction of Reliance Life Sciences
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Coherus BioSciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Coherus BioSciences
-
Figure Sales and Growth Rate Analysis of Coherus BioSciences
-
Figure Revenue and Market Share Analysis of Coherus BioSciences
-
Table Product and Service Introduction of Coherus BioSciences
-
Table Company Profile and Development Status of Allergan plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan plc
-
Figure Sales and Growth Rate Analysis of Allergan plc
-
Figure Revenue and Market Share Analysis of Allergan plc
-
Table Product and Service Introduction of Allergan plc
-
